DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression

Abstract

Multiple sclerosis is a chronic autoimmune disease of the central nervous system. It is the main cause of non-traumatic neurological disability in young adults. Multiple sclerosis mostly affects people aged 20–50 years; however, it can occur in young children and much older adults. Factors identified in the distribution of MS include age, gender, genetics, environment, and ethnic background. Multiple sclerosis is usually associated with progressive degrees of disability. The disease involves demyelination of axons of the central nervous system and causes brain and spinal cord neuronal loss and atrophy. Diagnosing multiple sclerosis is based on a patient’s medical history including symptoms, physical examination, and various tests such as magnetic resonance imaging, cerebrospinal fluid and blood tests, and electrophysiology. The disease course of multiple sclerosis is not well correlated with the biomarkers presently used in clinical practice. Blood-derived biomarkers that can detect and distinguish the different phenotypes in multiple sclerosis may be advantageous in personalized treatment with disease-modifying drugs and to predict response to treatment. The studies reviewed have shown that the expression levels of a large number of miRNAs in peripheral blood, serum, exosomes isolated from serum, and cerebrospinal fluid are altered in multiple sclerosis and can distinguish the diseasemore » phenotypes from each other. Further studies are warranted to independently validate these findings so that individual or pairs of miRNAs in serum or cerebrospinal fluid can be used as potential diagnostic markers for adult and pediatric multiple sclerosis and for monitoring disease progression and response to therapy.« less

Authors:
 [1];  [2]
  1. University of California, Merced, CA (United States); St. Georges University (Grenada); Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
  2. University of Otago, Dunedin (New Zealand)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
OSTI Identifier:
1628702
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Neural Regeneration Research
Additional Journal Information:
Journal Volume: 15; Journal Issue: 4; Journal ID: ISSN 1673-5374
Publisher:
Chinese Association of Rehabilitation Medicine (CARM)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; cell biology; neurosciences; neurology; clinically isolated syndrome; CSF; disease progression; exosomes; humans; microRNA; multiple sclerosis; peripheral blood; phenotypes; serum

Citation Formats

Martinez, Bridget, and Peplow, PhilipV. MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. United States: N. p., 2019. Web. doi:10.4103/1673-5374.266905.
Martinez, Bridget, & Peplow, PhilipV. MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. United States. https://doi.org/10.4103/1673-5374.266905
Martinez, Bridget, and Peplow, PhilipV. Fri . "MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression". United States. https://doi.org/10.4103/1673-5374.266905. https://www.osti.gov/servlets/purl/1628702.
@article{osti_1628702,
title = {MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression},
author = {Martinez, Bridget and Peplow, PhilipV},
abstractNote = {Multiple sclerosis is a chronic autoimmune disease of the central nervous system. It is the main cause of non-traumatic neurological disability in young adults. Multiple sclerosis mostly affects people aged 20–50 years; however, it can occur in young children and much older adults. Factors identified in the distribution of MS include age, gender, genetics, environment, and ethnic background. Multiple sclerosis is usually associated with progressive degrees of disability. The disease involves demyelination of axons of the central nervous system and causes brain and spinal cord neuronal loss and atrophy. Diagnosing multiple sclerosis is based on a patient’s medical history including symptoms, physical examination, and various tests such as magnetic resonance imaging, cerebrospinal fluid and blood tests, and electrophysiology. The disease course of multiple sclerosis is not well correlated with the biomarkers presently used in clinical practice. Blood-derived biomarkers that can detect and distinguish the different phenotypes in multiple sclerosis may be advantageous in personalized treatment with disease-modifying drugs and to predict response to treatment. The studies reviewed have shown that the expression levels of a large number of miRNAs in peripheral blood, serum, exosomes isolated from serum, and cerebrospinal fluid are altered in multiple sclerosis and can distinguish the disease phenotypes from each other. Further studies are warranted to independently validate these findings so that individual or pairs of miRNAs in serum or cerebrospinal fluid can be used as potential diagnostic markers for adult and pediatric multiple sclerosis and for monitoring disease progression and response to therapy.},
doi = {10.4103/1673-5374.266905},
journal = {Neural Regeneration Research},
number = 4,
volume = 15,
place = {United States},
year = {Fri Oct 18 00:00:00 EDT 2019},
month = {Fri Oct 18 00:00:00 EDT 2019}
}

Works referenced in this record:

Pediatric multiple sclerosis: a review
journal, March 2018


Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis
journal, May 2012

  • Angerstein, Charlotte; Hecker, Michael; Paap, Brigitte Katrin
  • Molecular Neurobiology, Vol. 45, Issue 3
  • DOI: 10.1007/s12035-012-8270-0

MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components
journal, April 2008


Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis
journal, December 2014


Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects
journal, July 2016

  • Backes, Christina; Meese, Eckart; Keller, Andreas
  • Molecular Diagnosis & Therapy, Vol. 20, Issue 6
  • DOI: 10.1007/s40291-016-0221-4

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
journal, March 2015


Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years
journal, March 2014

  • Benson, L. A.; Healy, B. C.; Gorman, M. P.
  • Multiple Sclerosis and Related Disorders, Vol. 3, Issue 2
  • DOI: 10.1016/j.msard.2013.06.004

A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog
journal, January 2016


MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
journal, October 2016

  • Catalanotto, Caterina; Cogoni, Carlo; Zardo, Giuseppe
  • International Journal of Molecular Sciences, Vol. 17, Issue 10
  • DOI: 10.3390/ijms17101712

Dicer Insufficiency and MicroRNA-155 Overexpression in Lupus Regulatory T Cells: An Apparent Paradox in the Setting of an Inflammatory Milieu
journal, December 2010

  • Divekar, Anagha A.; Dubey, Shweta; Gangalum, Pallavi R.
  • The Journal of Immunology, Vol. 186, Issue 2
  • DOI: 10.4049/jimmunol.1002218

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis
journal, October 2009

  • Du, Changsheng; Liu, Chang; Kang, Jiuhong
  • Nature Immunology, Vol. 10, Issue 12
  • DOI: 10.1038/ni.1798

Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
journal, March 2010


Exosomal microRNA signatures in multiple sclerosis reflect disease status
journal, October 2017


Non-coding RNAs in human disease
journal, November 2011

  • Esteller, Manel
  • Nature Reviews Genetics, Vol. 12, Issue 12
  • DOI: 10.1038/nrg3074

Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research
journal, October 2015


Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes
journal, July 2014


Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis
journal, November 2013

  • Fenoglio, Chiara; Ridolfi, Elisa; Cantoni, Claudia
  • Multiple Sclerosis Journal, Vol. 19, Issue 14
  • DOI: 10.1177/1352458513485654

The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
journal, March 2012


Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
journal, June 2013

  • Gandhi, Roopali; Healy, Brian; Gholipour, Taha
  • Annals of Neurology, Vol. 73, Issue 6
  • DOI: 10.1002/ana.23880

Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration
journal, January 2012


Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation
journal, November 2014


Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study
journal, October 2012


Biomarkers of multiple sclerosis: current findings
journal, January 2017

  • Harris, Violaine; Tuddenham, John; Sadiq, Saud
  • Degenerative Neurological and Neuromuscular Disease, Vol. Volume 7
  • DOI: 10.2147/DNND.S98936

MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
journal, August 2013

  • Hecker, Michael; Thamilarasan, Madhan; Koczan, Dirk
  • International Journal of Molecular Sciences, Vol. 14, Issue 8
  • DOI: 10.3390/ijms140816087

Biomarkers in multiple sclerosis
journal, November 2015


MicroRNAs associated with the pathogenesis of multiple sclerosis
journal, June 2016


Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients
journal, January 2015

  • Jafari, Naser; Shaghaghi, Hassan; Mahmoodi, Davood
  • Journal of Clinical Neuroscience, Vol. 22, Issue 1
  • DOI: 10.1016/j.jocn.2014.06.106

Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity
journal, October 2014

  • Jaworski, Maike; Marsland, Ben J.; Gehrig, Jasmine
  • The EMBO Journal, Vol. 33, Issue 23
  • DOI: 10.15252/embj.201488987

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)
journal, July 2013

  • Jernås, Margareta; Malmeström, Clas; Axelsson, Markus
  • BMC Immunology, Vol. 14, Issue 1
  • DOI: 10.1186/1471-2172-14-32

Pathophysiology of translational regulation by microRNAs in multiple sclerosis
journal, March 2011


MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
journal, December 2009

  • Junker, Andreas; Krumbholz, Markus; Eisele, Sylvia
  • Brain, Vol. 132, Issue 12
  • DOI: 10.1093/brain/awp300

Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity—Preliminary Study
journal, December 2014

  • Kacperska, Magdalena Justyna; Jastrzebski, Karol; Tomasik, Bartlomiej
  • Journal of Molecular Neuroscience, Vol. 56, Issue 1
  • DOI: 10.1007/s12031-014-0476-3

Systematic review of genome-wide expression studies in multiple sclerosis
journal, July 2011


Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions
journal, November 2007

  • Koning, Nathalie; Bö, Lars; Hoek, Robert M.
  • Annals of Neurology, Vol. 62, Issue 5
  • DOI: 10.1002/ana.21220

Epigenetics of Multiple Sclerosis: An Updated Review
journal, March 2014

  • Küçükali, Cem İsmail; Kürtüncü, Murat; Çoban, Arzu
  • NeuroMolecular Medicine, Vol. 17, Issue 2
  • DOI: 10.1007/s12017-014-8298-6

On the origin of EDSS
journal, March 2015


Circulating exosomes from patients with systemic lupus erythematosus induce a proinflammatory immune response
journal, November 2016

  • Lee, Joo Youn; Park, Jin Kyun; Lee, Eun Young
  • Arthritis Research & Therapy, Vol. 18, Issue 1
  • DOI: 10.1186/s13075-016-1159-y

Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease
journal, October 2017

  • Liguori, Maria; Nuzziello, Nicoletta; Licciulli, Flavio
  • Human Molecular Genetics, Vol. 27, Issue 1
  • DOI: 10.1093/hmg/ddx385

Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets
journal, August 2018


Defining the clinical course of multiple sclerosis: Results of an international survey
journal, April 1996


Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR
journal, May 2007

  • Lytle, J. R.; Yario, T. A.; Steitz, J. A.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 23
  • DOI: 10.1073/pnas.0703820104

Dicer and microRNA expression in multiple sclerosis and response to interferon therapy
journal, March 2016


A MicroRNA Targeting Dicer for Metastasis Control
journal, June 2010


Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis
journal, August 2015

  • Momen-Heravi, Fatemeh; Saha, Banishree; Kodys, Karen
  • Journal of Translational Medicine, Vol. 13, Issue 1
  • DOI: 10.1186/s12967-015-0623-9

Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability
journal, October 2017

  • Niwald, Marta; Migdalska-Sęk, Monika; Brzeziańska-Lasota, Ewa
  • Journal of Molecular Neuroscience, Vol. 63, Issue 3-4
  • DOI: 10.1007/s12031-017-0977-y

Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis
journal, November 2018

  • Nuzziello, Nicoletta; Vilardo, Laura; Pelucchi, Paride
  • International Journal of Molecular Sciences, Vol. 19, Issue 11
  • DOI: 10.3390/ijms19113652

microRNA Regulation of Inflammatory Responses
journal, April 2012


Multiple sclerosis genetics—is the glass half full, or half empty?
journal, July 2010


Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
journal, December 2016

  • Olsson, Tomas; Barcellos, Lisa F.; Alfredsson, Lars
  • Nature Reviews Neurology, Vol. 13, Issue 1
  • DOI: 10.1038/nrneurol.2016.187

Biomarkers in Multiple Sclerosis
journal, March 2018

  • Paul, Anu; Comabella, Manuel; Gandhi, Roopali
  • Cold Spring Harbor Perspectives in Medicine, Vol. 9, Issue 3
  • DOI: 10.1101/cshperspect.a029058

Integrated systems for exosome investigation
journal, October 2015


Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
journal, February 2011

  • Polman, Chris H.; Reingold, Stephen C.; Banwell, Brenda
  • Annals of Neurology, Vol. 69, Issue 2
  • DOI: 10.1002/ana.22366

What are exosomes and how can they be used in multiple sclerosis therapy?
journal, February 2014


miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands
journal, January 2017

  • Quintana, Ester; Ortega, Francisco José; Robles-Cedeño, René
  • Multiple Sclerosis Journal, Vol. 23, Issue 13
  • DOI: 10.1177/1352458516684213

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity
journal, March 2017


Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
journal, August 2016


Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
journal, April 2005


Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis
journal, May 2017

  • Selmaj, Igor; Cichalewska, Maria; Namiecinska, Magdalena
  • Annals of Neurology, Vol. 81, Issue 5
  • DOI: 10.1002/ana.24931

Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases
journal, December 2017

  • Sharaf-Eldin, Wessam E.; Kishk, Nirmeen A.; Gad, Yehia Z.
  • Journal of the Neurological Sciences, Vol. 383
  • DOI: 10.1016/j.jns.2017.11.014

Dicerablation in oligodendrocytes provokes neuronal impairment in mice
journal, December 2009

  • Shin, Daesung; Shin, Ji-Yeon; McManus, Michael T.
  • Annals of Neurology, Vol. 66, Issue 6
  • DOI: 10.1002/ana.21927

The role of miRNA in inflammation and autoimmunity
journal, October 2013


Differential microRNA expression in blood in multiple sclerosis
journal, June 2013

  • Søndergaard, Helle Bach; Hesse, Dan; Krakauer, Martin
  • Multiple Sclerosis Journal, Vol. 19, Issue 14
  • DOI: 10.1177/1352458513490542

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
journal, January 2008

  • Tzartos, John S.; Friese, Manuel A.; Craner, Matthew J.
  • The American Journal of Pathology, Vol. 172, Issue 1
  • DOI: 10.2353/ajpath.2008.070690

Circulating microRNAs as biomarkers in progressive multiple sclerosis
journal, July 2016

  • Vistbakka, Julia; Elovaara, Irina; Lehtimäki, Terho
  • Multiple Sclerosis Journal, Vol. 23, Issue 3
  • DOI: 10.1177/1352458516651141

Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients
journal, March 2018

  • Vistbakka, J.; Sumelahti, M. -L.; Lehtimäki, T.
  • Acta Neurologica Scandinavica, Vol. 138, Issue 2
  • DOI: 10.1111/ane.12921

The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis
journal, March 2017

  • Wang, Y. F.; He, D. D.; Liang, H. W.
  • Clinical and Experimental Immunology, Vol. 189, Issue 1
  • DOI: 10.1111/cei.12954

MicroRNA-Mediated Control of Oligodendrocyte Differentiation
journal, March 2010


Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction
journal, May 2014


Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity
journal, March 2017


Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
journal, February 2011

  • Polman, Chris H.; Reingold, Stephen C.; Banwell, Brenda
  • Annals of Neurology, Vol. 69, Issue 2
  • DOI: 10.1002/ana.22366

Epigenetics of Multiple Sclerosis: An Updated Review
journal, March 2014

  • Küçükali, Cem İsmail; Kürtüncü, Murat; Çoban, Arzu
  • NeuroMolecular Medicine, Vol. 17, Issue 2
  • DOI: 10.1007/s12017-014-8298-6

Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability
journal, October 2017

  • Niwald, Marta; Migdalska-Sęk, Monika; Brzeziańska-Lasota, Ewa
  • Journal of Molecular Neuroscience, Vol. 63, Issue 3-4
  • DOI: 10.1007/s12031-017-0977-y

Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis
journal, May 2012

  • Angerstein, Charlotte; Hecker, Michael; Paap, Brigitte Katrin
  • Molecular Neurobiology, Vol. 45, Issue 3
  • DOI: 10.1007/s12035-012-8270-0

The role of miRNA in inflammation and autoimmunity
journal, October 2013


Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets
journal, August 2018


A MicroRNA Targeting Dicer for Metastasis Control
journal, June 2010


Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation
journal, November 2014


Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes
journal, July 2014


MicroRNAs associated with the pathogenesis of multiple sclerosis
journal, June 2016


Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases
journal, December 2017

  • Sharaf-Eldin, Wessam E.; Kishk, Nirmeen A.; Gad, Yehia Z.
  • Journal of the Neurological Sciences, Vol. 383
  • DOI: 10.1016/j.jns.2017.11.014

Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients
journal, January 2015

  • Jafari, Naser; Shaghaghi, Hassan; Mahmoodi, Davood
  • Journal of Clinical Neuroscience, Vol. 22, Issue 1
  • DOI: 10.1016/j.jocn.2014.06.106

MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components
journal, April 2008


Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
journal, March 2010


Oligodendrocytes and the “Micro Brake” of Progenitor Cell Proliferation
journal, March 2010


Integrated systems for exosome investigation
journal, October 2015


Measurement and clinical effect of grey matter pathology in multiple sclerosis
journal, December 2012


The systematic search for risk factors in multiple sclerosis
journal, March 2015


Do patients with clinically isolated syndrome benefit from treatment with interferon β1b?
journal, February 2007


Non-coding RNAs in human disease
journal, November 2011

  • Esteller, Manel
  • Nature Reviews Genetics, Vol. 12, Issue 12
  • DOI: 10.1038/nrg3074

Multiple sclerosis genetics—is the glass half full, or half empty?
journal, July 2010


Natural History of Multiple Sclerosis with Childhood Onset
journal, June 2007

  • Renoux, Christel; Vukusic, Sandra; Mikaeloff, Yann
  • New England Journal of Medicine, Vol. 356, Issue 25
  • DOI: 10.1056/nejmoa067597

Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR
journal, May 2007

  • Lytle, J. R.; Yario, T. A.; Steitz, J. A.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 23
  • DOI: 10.1073/pnas.0703820104

The MicroRNA miR-191 Supports T Cell Survival Following Common γ Chain Signaling
journal, November 2016


MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
journal, December 2009

  • Junker, Andreas; Krumbholz, Markus; Eisele, Sylvia
  • Brain, Vol. 132, Issue 12
  • DOI: 10.1093/brain/awp300

Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease
journal, October 2017

  • Liguori, Maria; Nuzziello, Nicoletta; Licciulli, Flavio
  • Human Molecular Genetics, Vol. 27, Issue 1
  • DOI: 10.1093/hmg/ddx385

Classification, diagnosis, and differential diagnosis of multiple sclerosis
journal, June 2015


The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis
journal, March 2017

  • Wang, Y. F.; He, D. D.; Liang, H. W.
  • Clinical and Experimental Immunology, Vol. 189, Issue 1
  • DOI: 10.1111/cei.12954

Systematic review of genome-wide expression studies in multiple sclerosis
journal, July 2011


microRNA Regulation of Inflammatory Responses
journal, April 2012


Differential microRNA expression in blood in multiple sclerosis
journal, June 2013

  • Søndergaard, Helle Bach; Hesse, Dan; Krakauer, Martin
  • Multiple Sclerosis Journal, Vol. 19, Issue 14
  • DOI: 10.1177/1352458513490542

Circulating microRNAs as biomarkers in progressive multiple sclerosis
journal, July 2016

  • Vistbakka, Julia; Elovaara, Irina; Lehtimäki, Terho
  • Multiple Sclerosis Journal, Vol. 23, Issue 3
  • DOI: 10.1177/1352458516651141

miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands
journal, January 2017

  • Quintana, Ester; Ortega, Francisco José; Robles-Cedeño, René
  • Multiple Sclerosis Journal, Vol. 23, Issue 13
  • DOI: 10.1177/1352458516684213

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS)
journal, July 2013

  • Jernås, Margareta; Malmeström, Clas; Axelsson, Markus
  • BMC Immunology, Vol. 14, Issue 1
  • DOI: 10.1186/1471-2172-14-32

Pediatric multiple sclerosis: a review
journal, March 2018


Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis
journal, August 2015

  • Momen-Heravi, Fatemeh; Saha, Banishree; Kodys, Karen
  • Journal of Translational Medicine, Vol. 13, Issue 1
  • DOI: 10.1186/s12967-015-0623-9

Correction to: Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response
journal, May 2020


Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
journal, April 2016

  • Bergman, Petra; Piket, Eliane; Khademi, Mohsen
  • Neurology - Neuroimmunology Neuroinflammation, Vol. 3, Issue 3
  • DOI: 10.1212/nxi.0000000000000219

Identification of MS-specific serum miRNAs in an international multicenter study
journal, August 2018


MicroRNAs in the CSF: Macro-advance in MS?
journal, October 2012


Early onset multiple sclerosis: A longitudinal study
journal, October 2002


The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
journal, March 2012


A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog
journal, January 2016


MALT 1 protease: equilibrating immunity versus tolerance
journal, October 2014


What are exosomes and how can they be used in multiple sclerosis therapy?
journal, February 2014


Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research
journal, October 2015


Interleukin-17—Extended Features of a Key Player in Multiple Sclerosis
journal, January 2008


MicroRNA dysregulation in multiple sclerosis
journal, January 2013


Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
journal, January 2013


MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
journal, August 2013

  • Hecker, Michael; Thamilarasan, Madhan; Koczan, Dirk
  • International Journal of Molecular Sciences, Vol. 14, Issue 8
  • DOI: 10.3390/ijms140816087

MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
journal, October 2016

  • Catalanotto, Caterina; Cogoni, Carlo; Zardo, Giuseppe
  • International Journal of Molecular Sciences, Vol. 17, Issue 10
  • DOI: 10.3390/ijms17101712

Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis
journal, November 2018

  • Nuzziello, Nicoletta; Vilardo, Laura; Pelucchi, Paride
  • International Journal of Molecular Sciences, Vol. 19, Issue 11
  • DOI: 10.3390/ijms19113652

Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction
journal, May 2014